| Schedule of maturity of financial liabilities |
Schedule of maturity of
financial liabilities
|
December 31, 2022
|
|
Carrying
amounts |
|
|
Total |
|
|
2 months
or less |
|
|
2-12
months |
|
|
12-24 months
|
|
|
More
than 2 years
|
|
|
December 31, 2022
|
|
Carrying
amounts |
|
|
Total |
|
|
2 months
or less |
|
|
2-12
months |
|
|
12-24 months
|
|
|
More
than 2 years
|
|
| Financial liabilities |
|
£ |
|
|
£ |
|
|
£ |
|
|
£ |
|
|
£ |
|
|
£ |
|
| Trade payables |
|
|
882,364 |
|
|
|
882,364 |
|
|
|
882,364 |
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
| Convertible loan |
|
|
655,923 |
|
|
|
655,923 |
|
|
|
655,923 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Other payables |
|
|
1,276,694 |
|
|
|
1,276,694 |
|
|
|
705,976 |
|
|
|
570,718 |
|
|
|
- |
|
|
|
- |
|
| Financial liabilities |
|
|
2,814,981 |
|
|
|
2,814,981 |
|
|
|
2,244,263 |
|
|
|
570,718 |
|
|
|
- |
|
|
|
- |
|
|
December 31, 2021
|
|
Carrying
amounts |
|
|
Total |
|
|
2 months
or less |
|
|
2-12
months |
|
|
12-24 months
|
|
|
More
than 2 years
|
|
| Financial liabilities |
|
£ |
|
|
£ |
|
|
£ |
|
|
£ |
|
|
£ |
|
|
£ |
|
| Trade payables |
|
|
1,422,393 |
|
|
|
1,422,393 |
|
|
|
1,422,393 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Convertible loan |
|
|
13,731,864 |
|
|
|
20,359,893 |
|
|
|
10,088,496 |
|
|
|
10,271,397 |
|
|
|
|
|
|
|
|
|
| Other payables |
|
|
2,681,223 |
|
|
|
2,681,223 |
|
|
|
831,029 |
|
|
|
1,850,194 |
|
|
|
-
|
|
|
|
- |
|
| Financial liabilities |
|
|
17,835,480 |
|
|
|
24,463,509 |
|
|
|
12,341,918 |
|
|
|
12,121,591 |
|
|
|
- |
|
|
|
- |
|
|
| Schedule of lease liabilities |
Schedule
of lease liabilities
| |
|
January 1,
2022 |
|
|
Cash
flows |
|
|
New
leases |
|
|
Other |
|
|
December 31,
2022 |
|
| |
|
£ |
|
|
£ |
|
|
£ |
|
|
£ |
|
|
£ |
|
| Current lease liabilities |
|
|
765,758 |
|
|
|
(762,150 |
) |
|
|
-
|
|
|
|
324,425 |
|
|
|
328,033 |
|
| Convertible loan notes |
|
|
13,731,864 |
|
|
|
(2,632,324 |
) |
|
|
- |
|
|
|
(10,443,617 |
) |
|
|
655,923 |
|
| Non-current lease liabilities |
|
|
2,136,875 |
|
|
|
- |
|
|
|
- |
|
|
|
(324,425 |
) |
|
|
1,812,450 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
16,634,497 |
|
|
|
(3,394,474 |
) |
|
|
- |
|
|
|
(10,443,617 |
) |
|
|
2,796,406 |
|
TC
BIOPHARM (HOLDINGS) PLC
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
24. Risk management (continued)
| |
|
January 1,
2021 |
|
|
Cash
flows |
|
|
New
leases |
|
|
Other |
|
|
December 31,
2021 |
|
| |
|
£ |
|
|
£ |
|
|
£ |
|
|
£ |
|
|
£ |
|
| Current lease liabilities |
|
|
442,702 |
|
|
|
(122,469 |
) |
|
|
-
|
|
|
|
445,525 |
|
|
|
765,758 |
|
| Convertible loan notes |
|
|
- |
|
|
|
6,383,659 |
|
|
|
- |
|
|
|
7,348,205 |
|
|
|
13,731,864 |
|
| Non-current lease liabilities |
|
|
2,582,400 |
|
|
|
- |
|
|
|
- |
|
|
|
(445,525 |
) |
|
|
2,136,875 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
3,025,102 |
|
|
|
6,261,190 |
|
|
|
- |
|
|
|
7,348,205 |
|
|
|
16,634,497 |
|
|